The subject of the contract is: delivery of medicines in the drug program for the treatment of cystic fibrosis:
Package No. 1
1) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tabletek (Ka-ftrio) op. 390
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco) op. 390
Package No. 2
1) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tabletek (Symkevi) op. 60
2) Ivacaftorum 75 mg x 28 tabletek (Kalydeco) on. 60
Package No. 3
1) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tabletek (Symkevi) on. 120
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco) op. 120
Package No. 4
1) Ivacaftorum + Lumacaftorum (Orkambi) granules 188 mg + 150 mg x 56 saszetek op. 40
The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".
The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.
Package No. 1Package No. 1
1) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tabletek (Ka-ftrio) op. 390
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco) op. 390
Package No. 2Package No. 2
1) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tabletek (Symkevi) op. 60
2) Ivacaftorum 75 mg x 28 tabletek (Kalydeco) on. 60
Package No. 3Package No. 3
1) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tabletek (Symkevi) on. 120
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco) op. 120
Package No. 4Package No. 4
1) Ivacaftorum + Lumacaftorum (Orkambi) granules 188 mg + 150 mg x 56 saszetek op. 40